[BidClub_]

PERSON DIRECTORY

Allison DeAngelis

Allison DeAngelis appears in 2 indexed conversations across Biotech Hangout. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.

2 EPISODES1 SHOW
1 episode1 active
Language
Biotech HangoutEN · 58 min

Episode 163 -- November 14, 2025

John MaraganoreYaron WerberAmi FadiaAllison DeAngelisDrew Armstrong

Rick Pazdur’s CDER appointment may steady FDA leadership, but the vague “plausible mechanism pathway” and its apparent conflict with uniQure keep regulatory execution a key risk.Competitive M&A—Lundbeck’s $2.6B Avadel bid versus Alkermes’ $2.1B offer—and Cogent’s PEAK, with 16.5-month mPFS in second-line GIST, create catalysts, while Intellia’s clinical hold keeps gene-editing safety unresolved.